Supernus Pharmaceuticals | SUPN - Ordinary Share Capital


Supernus Pharmaceuticals reported $58.16M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Abbott USD 1.74B 2.94M Mar/2026
ANI Pharmaceuticals USD 22.49M 760K Dec/2025
Aurora Cannabis CAD 58.95M 2.24M Mar/2026
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Canopy Growth CAD 422.07M 53.78M Mar/2026
Cara Therapeutics USD 9.38M 2.01K Mar/2026
Corcept Therapeutics USD 107.33M 1.36M Mar/2026
Eisai JPY 282.46M 345K Jun/2026
Eli Lilly USD 943.5M 3.33M Mar/2026
Novo Nordisk DKK 4.43B 13.25M Jun/2026
Pacira USD 39.82M 512K Jun/2026
Perrigo USD 138.1M 500K Mar/2026
Pfizer USD 5.7B 0 Jun/2026
Supernus Pharmaceuticals USD 58.16M 124K Jun/2026
United Therapeutics USD 42.68M 521K Jun/2026
Xeris Pharmaceuticals USD 172.56M 6.34M Mar/2026